JP2003512348A5 - - Google Patents

Download PDF

Info

Publication number
JP2003512348A5
JP2003512348A5 JP2001531783A JP2001531783A JP2003512348A5 JP 2003512348 A5 JP2003512348 A5 JP 2003512348A5 JP 2001531783 A JP2001531783 A JP 2001531783A JP 2001531783 A JP2001531783 A JP 2001531783A JP 2003512348 A5 JP2003512348 A5 JP 2003512348A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2001531783A
Other languages
Japanese (ja)
Other versions
JP2003512348A (ja
JP3632191B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2000/028687 external-priority patent/WO2001028978A1/en
Publication of JP2003512348A publication Critical patent/JP2003512348A/ja
Application granted granted Critical
Publication of JP3632191B2 publication Critical patent/JP3632191B2/ja
Publication of JP2003512348A5 publication Critical patent/JP2003512348A5/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2001531783A 1999-10-20 2000-10-17 医薬製剤としての2環式アミノ酸 Expired - Fee Related JP3632191B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US16072599P 1999-10-20 1999-10-20
US60/160,725 1999-10-20
PCT/US2000/028687 WO2001028978A1 (en) 1999-10-20 2000-10-17 Bicyclic amino acids as pharmaceutical agents

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2004266488A Division JP3744928B2 (ja) 1999-10-20 2004-09-14 医薬製剤としての2環式アミノ酸

Publications (3)

Publication Number Publication Date
JP2003512348A JP2003512348A (ja) 2003-04-02
JP3632191B2 JP3632191B2 (ja) 2005-03-23
JP2003512348A5 true JP2003512348A5 (enExample) 2005-12-22

Family

ID=22578159

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2001531783A Expired - Fee Related JP3632191B2 (ja) 1999-10-20 2000-10-17 医薬製剤としての2環式アミノ酸
JP2004266488A Expired - Fee Related JP3744928B2 (ja) 1999-10-20 2004-09-14 医薬製剤としての2環式アミノ酸

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2004266488A Expired - Fee Related JP3744928B2 (ja) 1999-10-20 2004-09-14 医薬製剤としての2環式アミノ酸

Country Status (50)

Country Link
US (2) US6689906B1 (enExample)
EP (2) EP1506955B1 (enExample)
JP (2) JP3632191B2 (enExample)
KR (2) KR100566462B1 (enExample)
CN (1) CN1165518C (enExample)
AP (2) AP2004003186A0 (enExample)
AR (2) AR026087A1 (enExample)
AT (2) ATE293590T1 (enExample)
AU (2) AU778871B2 (enExample)
BG (2) BG108860A (enExample)
BR (1) BR0014972B1 (enExample)
CA (1) CA2386297C (enExample)
CO (1) CO5280060A1 (enExample)
CR (1) CR6620A (enExample)
CU (1) CU23112A3 (enExample)
CZ (1) CZ295960B6 (enExample)
DE (2) DE60019628T2 (enExample)
DO (1) DOP2000000083A (enExample)
DZ (1) DZ3197A1 (enExample)
EA (1) EA005206B1 (enExample)
EC (1) ECSP045393A (enExample)
EE (1) EE200200211A (enExample)
ES (2) ES2282785T3 (enExample)
GE (1) GEP20043297B (enExample)
GT (2) GT200000183AA (enExample)
HK (1) HK1049826B (enExample)
HN (1) HN2000000224A (enExample)
HR (2) HRP20020428B1 (enExample)
HU (1) HUP0203325A3 (enExample)
IL (3) IL164060A0 (enExample)
IS (2) IS6348A (enExample)
MA (1) MA26842A1 (enExample)
MX (1) MXPA02003229A (enExample)
MY (1) MY127678A (enExample)
NO (2) NO20021780D0 (enExample)
NZ (1) NZ517961A (enExample)
OA (1) OA12070A (enExample)
PA (1) PA8505201A1 (enExample)
PE (1) PE20010740A1 (enExample)
PL (1) PL354607A1 (enExample)
PT (1) PT1226110E (enExample)
SI (1) SI1226110T1 (enExample)
SK (1) SK5232002A3 (enExample)
SV (1) SV2001000188A (enExample)
TR (2) TR200201094T2 (enExample)
TW (2) TWI225855B (enExample)
UA (1) UA72931C2 (enExample)
WO (1) WO2001028978A1 (enExample)
YU (2) YU73004A (enExample)
ZA (1) ZA200202543B (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7164034B2 (en) 1999-06-10 2007-01-16 Pfizer Inc. Alpha2delta ligands for fibromyalgia and other disorders
MXPA02010668A (es) * 2000-06-26 2003-03-10 Warner Lambert Co Analogos de gabapentina para alteraciones del sueno.
US6620829B2 (en) 2000-10-17 2003-09-16 Warner-Lambert Company Method of treating noninflammatory cartilage damage
EP1226820A1 (en) * 2001-01-26 2002-07-31 Warner-Lambert Company Use of bicyclic amino acids for preventing and treating visceral pain and gastrointestinal disorders
EA006396B1 (ru) 2001-04-19 2005-12-29 УОРНЕР-ЛАМБЕРТ КОМПАНИ Эл Эл Си Конденсированные бициклические аминокислоты
GB2375108A (en) * 2001-05-04 2002-11-06 Warner Lambert Co Production of a bicycloheptanone
GB2375109A (en) * 2001-05-04 2002-11-06 Warner Lambert Co Process for preparing bicyclic amino acid
US6818787B2 (en) 2001-06-11 2004-11-16 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7186855B2 (en) 2001-06-11 2007-03-06 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
US7232924B2 (en) 2001-06-11 2007-06-19 Xenoport, Inc. Methods for synthesis of acyloxyalkyl derivatives of GABA analogs
WO2002100347A2 (en) * 2001-06-11 2002-12-19 Xenoport, Inc. Prodrugs of gaba analogs, compositions and uses thereof
KR20040081478A (ko) 2002-01-31 2004-09-21 워너-램버트 캄파니 엘엘씨 이명을 치료하기 위한 알파 2 델타 리간드
IL162932A0 (en) * 2002-02-22 2005-11-20 Warner Lambert Co Combinations of an alpha-2-delta ligand with a selective inhibitor of cyclooxygenase-2
AU2003239752A1 (en) * 2002-06-27 2004-01-19 Warner-Lambert Company Llc Use of an alpha2delta ligand such as gabapentin or pregabalin for treating ttention deficit hyperactivity disorder
US7419981B2 (en) 2002-08-15 2008-09-02 Pfizer Inc. Synergistic combinations of an alpha-2-delta ligand and a cGMP phosphodieterse 5 inhibitor
CA2494811A1 (en) * 2002-08-15 2004-02-26 Pfizer Inc. Therapeutic use of fused bicyclic or tricyclic amino acids
GB0219024D0 (en) * 2002-08-15 2002-09-25 Pfizer Ltd Synergistic combinations
GB0223072D0 (en) 2002-10-04 2002-11-13 Pfizer Ltd Cyclic nitromethyl acetic acid derivatives
US7018818B2 (en) 2002-10-04 2006-03-28 Pfizer Inc. Intermediates in the preparation of therapeutic fused bicyclic amino acids
AU2003297927A1 (en) 2002-12-11 2004-06-30 Xenoport, Inc. Prodrugs of fused gaba analogs, pharmaceutical compositions and uses thereof
ES2341240T3 (es) 2002-12-13 2010-06-17 Warner-Lambert Company Llc Ligando alfa-2-delta para tratar los sintomas del tracto urinario inferior.
CA2451267A1 (en) 2002-12-13 2004-06-13 Warner-Lambert Company Llc Pharmaceutical uses for alpha2delta ligands
KR20050085636A (ko) 2002-12-13 2005-08-29 워너-램버트 캄파니 엘엘씨 섬유근육통 및 기타 질환의 치료를 위한 프레가발린 유도체
MXPA06002789A (es) 2003-09-12 2006-06-14 Pfizer Combinaciones que comprenden ligandos alfa-2-delta.
WO2006092692A1 (en) * 2005-03-01 2006-09-08 Pfizer Limited Use of combinations of pde7 inhibitors and alpha-2-delty ligands for the treatment of neuropathic pain
AR061728A1 (es) * 2006-06-30 2008-09-17 Pfizer Prod Inc Composicion para tratamiento usando compuestos selectivos alfa-2-delta-1
UA94979C2 (uk) 2006-12-22 2011-06-25 Рекордати Айеленд Лимитед КОМБІНОВАНА ТЕРАПІЯ ПОРУШЕНЬ НИЖНІХ СЕЧОВИВІДНИХ ШЛЯХІВ ЛІГАНДАМИ α2δ І НПЗП
BR122013020635A2 (pt) 2007-09-28 2019-08-06 Daiichi Sankyo Company, Limited Composto
CA2756750C (en) 2009-03-26 2014-05-13 Daiichi Sankyo Company, Limited A method for producing bicyclic .gamma.-amino acid derivative
CN103582622B (zh) 2011-06-08 2015-06-10 第一三共株式会社 经由亚胺鎓盐制备双环化合物的方法
KR101816337B1 (ko) 2011-06-08 2018-01-08 다이이찌 산쿄 가부시키가이샤 클라이젠 전위 반응에 의한 2 고리성 화합물의 제조 방법
IN2014MN01046A (enExample) 2011-12-15 2015-05-01 Daiichi Sankyo Companyltd
EP2837689B1 (en) 2012-04-10 2017-02-15 Daiichi Sankyo Company, Limited Optical resolution method for bicyclic compound using enzyme
US9066853B2 (en) 2013-01-15 2015-06-30 Warsaw Orthopedic, Inc. Clonidine compounds in a biodegradable fiber
TWI635071B (zh) 2013-07-08 2018-09-11 第一三共股份有限公司 光學活性二環γ-胺基酸衍生物及其製造方法
WO2018166855A1 (en) 2017-03-16 2018-09-20 Basf Se Heterobicyclic substituted dihydroisoxazoles
CN113045410A (zh) * 2021-03-29 2021-06-29 华东理工大学 一种双环降二萜类化合物及其合成基因及制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3641129A (en) 1969-06-17 1972-02-08 Merck & Co Inc Antifibrinolytic compounds
DE2460891C2 (de) 1974-12-21 1982-09-23 Gödecke AG, 1000 Berlin 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US4087544A (en) * 1974-12-21 1978-05-02 Warner-Lambert Company Treatment of cranial dysfunctions using novel cyclic amino acids
DE69834204T2 (de) 1997-10-27 2007-03-29 Warner-Lambert Co. Llc Zyklische aminosäuren und deren derivate als arzneimittel

Similar Documents

Publication Publication Date Title
BE2017C009I2 (enExample)
LU91650I9 (enExample)
JP2000222331A5 (enExample)
JP2003504712A5 (enExample)
JP2003521324A5 (enExample)
BRPI0113420B8 (enExample)
BRPI0113085B8 (enExample)
JP2003509681A5 (enExample)
JP2003516065A5 (enExample)
JP2003516610A5 (enExample)
JP2004503037A5 (enExample)
JP2001179938A5 (enExample)
JP2000310884A5 (enExample)
BRPI0113372A8 (enExample)
JP2002150195A5 (enExample)
JP2002160752A5 (enExample)
JP2002143650A5 (enExample)
JP2002184570A5 (enExample)
BY5768C1 (enExample)
CN3144928S (enExample)
CN3135789S (enExample)
CN3141410S (enExample)
CN3141398S (enExample)
CN3141017S (enExample)
CN3141006S (enExample)